When it comes to stem cells, the public -- and the media -- tend to focus on embryos. But researchers and analysts say marketable therapies already are emerging from less controversial work with adult stem cells.
Business and financial news - CNNMoney.com, CNN: Business
Tue, 06/16/2009 - 11:55am
When it comes to stem cells, the public -- and the media -- tend to focus on embryos. But researchers and analysts say marketable therapies already are emerging from less controversial work with adult stem cells.